Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.34 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.34 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.34 |
| ▸ | PDGFRB | P09619 | 3/20 | 0.32 |
| ▸ | PDGFRA | P16234 | 3/20 | 0.32 |
| ▸ | POLB | P06746 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | G6PD | P11413 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | NQO2 | P16083 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12313241 | 0.95 | EHMT2 (0.32) | CYP19A1CYP11B1CYP11B2PDGFRBPDGFRA | |
| SCHEMBL12313251 | 0.92 | CYP19A1 (0.35) | CYP19A1CYP11B1CYP11B2PDGFRBPDGFRA | |
| SCHEMBL12313231 | 0.86 | PDE10A (0.38) | MAPT | |
| SCHEMBL12313242 | 0.82 | PDE10A (0.39) | — | |
| SCHEMBL13870826 | 0.82 | PDGFRB (0.39) | PDGFRBPDGFRAPOLBNPC1LMNA | |
| SCHEMBL13399656 | 0.80 | PDGFRB (0.37) | PDGFRBPDGFRAPOLBNPC1LMNA | |
| SCHEMBL12313230 | 0.80 | MAOA (0.39) | CYP11B1CYP11B2PDGFRBPDGFRAPOLB | |
| SCHEMBL12313220 | 0.80 | MAOA (0.41) | PDGFRBPDGFRAPOLBLMNAPKM | |
| SCHEMBL12313252 | 0.79 | PDE10A (0.39) | — | |
| SCHEMBL12313237 | 0.79 | IGF1R (0.36) | CYP19A1PDGFRBNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8263237-B2 | Red phosphorescent composition and organic electroluminescent device using the same | LG DISPLAY CO., LTD (KR) | 2012-09-11 | — | — | US | disclosed |
| US-8263237-B2 | Red phosphorescent composition and organic electroluminescent device using the same | LG DISPLAY CO., LTD (KR) | 2012-09-11 | — | — | US | disclosed |
| US-20100102714-A1 | Red phosphorescent compound and organic electroluminescent device using the same | LG DISPLAY CO., LTD. (KR) | 2010-04-29 | — | — | US | disclosed |
| US-20100102714-A1 | Red phosphorescent compound and organic electroluminescent device using the same | LG DISPLAY CO., LTD. (KR) | 2010-04-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100102714-A1 | Red phosphorescent compound and organic electroluminescent device using the same | YTHDC1, IK, PYCR1 | CYP19A1 2541/4885CYP11B1 2952/4885CYP11B2 3287/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.